📊 MPT Key Takeaways
Is Medical Properties Trust Inc. (MPT) a Good Investment?
Medical Properties Trust is experiencing severe operational distress with significant negative profitability across all major metrics despite maintaining positive operating cash flow. The company is burning through equity with negative net income of -$277M, negative operating margins of -24.4%, and deteriorating returns (ROE of -6.0%, ROA of -1.8%). High leverage (2.11x Debt/Equity) combined with negative interest coverage of -0.5x indicates substantial financial stress and limited ability to service debt obligations.
Fundamentals are weak: revenue is declining, operating and net income are negative, and interest coverage is -0.5x, indicating earnings do not cover financing costs. High leverage (2.11x D/E, $9.7B long-term debt) magnifies refinancing and covenant risk despite positive operating cash flow. Until operating profitability and coverage improve, balance sheet risk outweighs upside.
Why Buy Medical Properties Trust Inc. Stock? MPT Key Strengths
- Positive operating cash flow of $230.8M provides near-term liquidity relief
- Strong free cash flow margin of 23.7% relative to revenue suggests some underlying operational efficiency in cash generation
- Substantial asset base of $15.0B provides collateral and potential restructuring flexibility
- Positive operating cash flow and 23.7% FCF margin
- Large asset base ($15.0B) with $4.61B equity
- Cash on hand of $540.86M provides some liquidity
MPT Stock Risks: Medical Properties Trust Inc. Investment Risks
- Consistent negative profitability with -$277M net loss and -24.4% operating margin indicates fundamental operational problems
- Critical negative interest coverage (-0.5x) signals inability to cover debt service from operating earnings, creating default risk
- Elevated leverage ratio of 2.11x Debt/Equity ($9.7B long-term debt) with deteriorating equity position creates refinancing risk and limits financial flexibility
- Declining revenue (-2.4% YoY) combined with operational losses suggests market headwinds in the healthcare real estate sector
- Sustained losses with -24.4% operating and -28.5% net margins
- Negative interest coverage (-0.5x) suggests inability to service debt from operations
- High leverage (2.11x D/E) alongside -2.4% YoY revenue decline
Key Metrics to Watch
- Quarterly operating income trend and path to profitability
- Debt-to-EBITDA ratio and debt refinancing schedules
- Cash flow from operations sustainability and capital allocation decisions
- Revenue stabilization and occupancy rates at portfolio properties
- Interest coverage ratio recovery to positive territory
- Interest coverage
- Operating cash flow trend and sustainability
Medical Properties Trust Inc. (MPT) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The 23.7% free cash flow margin provides substantial flexibility for dividends, buybacks, and strategic investments. The current ratio below 1.0x warrants monitoring of short-term liquidity.
MPT Profit Margin, ROE & Profitability Analysis
MPT vs Real Estate Sector: How Medical Properties Trust Inc. Compares
How Medical Properties Trust Inc. compares to Real Estate sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Medical Properties Trust Inc. Stock Overvalued? MPT Valuation Analysis 2026
Based on fundamental analysis, Medical Properties Trust Inc. shows some fundamental concerns relative to the Real Estate sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Medical Properties Trust Inc. Balance Sheet: MPT Debt, Cash & Liquidity
MPT Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Medical Properties Trust Inc.'s revenue has declined by 36% over the 5-year period, indicating business contraction. The most recent EPS of $-0.93 indicates the company is currently unprofitable.
MPT Revenue Growth, EPS Growth & YoY Performance
MPT Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $225.8M | -$77.7M | $-0.13 |
| Q2 2025 | $240.4M | -$98.4M | $-0.16 |
| Q1 2025 | $223.8M | -$118.3M | $-0.20 |
| Q3 2024 | $225.8M | $107.5M | $0.18 |
| Q2 2024 | $266.6M | -$9.2M | $-0.02 |
| Q1 2024 | $271.3M | $32.8M | $0.05 |
| Q3 2023 | $306.6M | $107.5M | $0.18 |
| Q2 2023 | $337.4M | -$9.2M | $-0.02 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Medical Properties Trust Inc. Dividends, Buybacks & Capital Allocation
MPT SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Medical Properties Trust Inc. (CIK: 0001287865)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MPT
What is the AI rating for MPT?
Medical Properties Trust Inc. (MPT) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 83% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are MPT's key strengths?
Claude: Positive operating cash flow of $230.8M provides near-term liquidity relief. Strong free cash flow margin of 23.7% relative to revenue suggests some underlying operational efficiency in cash generation. ChatGPT: Positive operating cash flow and 23.7% FCF margin. Large asset base ($15.0B) with $4.61B equity.
What are the risks of investing in MPT?
Claude: Consistent negative profitability with -$277M net loss and -24.4% operating margin indicates fundamental operational problems. Critical negative interest coverage (-0.5x) signals inability to cover debt service from operating earnings, creating default risk. ChatGPT: Sustained losses with -24.4% operating and -28.5% net margins. Negative interest coverage (-0.5x) suggests inability to service debt from operations.
What is MPT's revenue and growth?
Medical Properties Trust Inc. reported revenue of $972.0M.
Does MPT pay dividends?
Medical Properties Trust Inc. does not currently pay dividends.
Where can I find MPT SEC filings?
Official SEC filings for Medical Properties Trust Inc. (CIK: 0001287865) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MPT's EPS?
Medical Properties Trust Inc. has a diluted EPS of $-0.46.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is MPT a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Medical Properties Trust Inc. has a STRONG SELL rating with 83% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is MPT stock overvalued or undervalued?
Valuation metrics for MPT: ROE of -6.0% (sector avg: 8%), net margin of -28.5% (sector avg: 20%). Compare these metrics with sector averages to assess valuation.
Should I buy MPT stock in 2026?
Our dual AI analysis gives Medical Properties Trust Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MPT's free cash flow?
Medical Properties Trust Inc.'s operating cash flow is $230.8M, with capital expenditures of N/A. FCF margin is 23.7%.
How does MPT compare to other Real Estate stocks?
Vs Real Estate sector averages: Net margin -28.5% (avg: 20%), ROE -6.0% (avg: 8%), current ratio N/A (avg: 1.5).
Is Medical Properties Trust Inc. carrying too much debt?
MPT has a debt-to-equity ratio of 2.11x, which is above the Real Estate sector average of 1.5x. Combined with a current ratio below 1, this warrants careful monitoring of the balance sheet.